Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Imaging (MI), Molecular Therapeutics (MT) and Population Studies and Disparities Research (PSDR).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

Other Karmanos Programs

The Latest From Karmanos Cancer Institute

News

Karmanos’ Community Outreach and Engagement Office Honored as Hometown Health Hero by the Michigan Public Health Week Partnership

The Barbara Ann Karmanos Cancer Institute’s Office of Community Outreach and Engagement (COE) has been named a 2025 Hometown Health Hero by the Mi...

Read More

Karmanos Recommended Nationwide by Optum for Transplants

The Barbara Ann Karmanos Cancer Institute has been named one of 168 medical centers in the country to which Optum recommends its payers refer thei...

Read More

The HPV Link: Understanding How It Can Lead to Head and Neck Cancer

Human papillomavirus (HPV) is common and widespread virus, and about 85% of people will get an HPV infection in their lives. According to the Cent...

Read More
News

WDET | Doctor Says HPV Vaccine and Routine Screenings Aid Against Cervical Cancer

Listen Now

WWJ | World Cancer Day

Listen Now

WWJ | Ribbon Cutting Held for New Karmanos Cancer Center in Dearborn That Strives to Improve Access to Treatment, Clinical Trials

Listen Now